This is an infection caused by a type of virus called a lentivirus. These viruses can affect many parts of your body and stay in your system for a long time. Think of it like a long-lasting infection that can affect different organs.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Lentivirus infections are long-lasting infections caused by lentiviruses, a group of retroviruses that settle into the body for life and cause disease slowly, often over years. In people, the lentivirus that matters is the human immunodeficiency virus (HIV). Other members of the group infect animals such as cats, horses, monkeys, sheep and goats, and are mainly a concern for veterinary medicine and research. HIV damages the immune system by destroying CD4 cells, a type of white blood cell that helps the body fight infection. Without treatment, the gradual loss of these cells leaves the body less able to control other infections and some cancers. The most advanced stage is called AIDS (acquired immunodeficiency syndrome). With modern treatment, HIV can be kept under control, and people who start treatment early can expect to live about as long as people without the virus. There are two types. HIV-1 is the main type worldwide. HIV-2, which affects an estimated one to two million people, mostly in West Africa and among people with ties to the region, usually spreads less easily and progresses more slowly. It still causes illness without treatment, and it needs some different tests and medicines.
HIV passes between people through certain body fluids: blood, semen and pre-seminal fluid, vaginal and rectal fluids, and breast milk. Most infections come from anal or vaginal sex without a condom or HIV-prevention medicine, and from sharing needles or other drug-injecting equipment. HIV can also pass to a baby during pregnancy, birth or breastfeeding. It does not spread through hugging, shaking hands, sharing dishes or toilet seats, through the air or water, or by insect bites. Some situations raise the chance of infection. Having another sexually transmitted infection (STI) makes it easier to acquire or pass on HIV. In the United States, gay and bisexual men and people who share injecting equipment are at higher risk, and Black and Hispanic/Latino Americans make up a larger share of new diagnoses. Stigma, discrimination, income, education and where someone lives all affect access to testing, prevention and care, which helps explain those differences. For any one person, what matters is the exposure itself. The amount of virus in the body drives transmission. HIV spreads most easily in the first weeks after infection, when virus levels in the blood are very high, and from people who do not know they have it. A person with HIV who takes treatment and keeps the virus at undetectable levels does not pass it on through sex.
HIV is diagnosed with a blood test, or sometimes an oral fluid test. Because many people feel well for years, testing is the only way to know. The US Centers for Disease Control and Prevention (CDC) recommends that everyone aged 13 to 64 be tested at least once as part of routine care, that people with ongoing risk be tested at least yearly, and that everyone be tested during pregnancy. Three kinds of test are used. Antibody tests look for the immune system's response to HIV; most rapid tests and home self-tests work this way. Antigen/antibody tests, the most common lab test, also detect a piece of the virus itself, which appears sooner than antibodies. Nucleic acid tests (NATs) look for the virus's genetic material and can usually detect infection 10 to 33 days after exposure. Every test has a window period, the time after exposure when infection is present but not yet detectable, so a negative result soon after a possible exposure may need repeating. A positive result is always confirmed with a follow-up test. Testing can also tell HIV-1 from HIV-2, which matters because HIV-2 responds differently to some medicines and needs its own viral load test, which is less widely available. After diagnosis, two measurements guide care. The viral load is the amount of HIV in the blood; the goal of treatment is to make it undetectable, meaning too low for a standard test to measure. The CD4 count shows how much of the immune system has been affected. A CD4 count below 200 cells per cubic millimeter of blood, or certain serious infections that take advantage of a weakened immune system, means HIV has progressed to AIDS.
There is no cure for HIV, but treatment works very well. Antiretroviral therapy (ART) is a combination of HIV medicines that stops the virus from making copies of itself. That lowers the viral load, lets the immune system rebuild its CD4 cells and prevents progression to AIDS. ART is recommended for everyone with HIV, started as soon as possible after diagnosis. Many people take their combination as a single pill once a day. Long-acting injections, given by a clinician on schedules that range from every two weeks to every six months depending on the medicine, may suit some people. HIV medicines fall into seven classes according to how they block the virus, and a regimen is chosen around a person's other health conditions, other medicines (some interact with HIV drugs), pregnancy plans and side effects. Most side effects are manageable and a few can be serious, so any change should go through the prescriber rather than stopping on one's own. Taking medicines consistently is what makes treatment work. Missed doses give the virus room to multiply again and can lead to drug resistance, where a medicine no longer controls the virus. HIV-2 needs a tailored regimen. It is naturally resistant to one class of HIV medicines, the non-nucleoside reverse transcriptase inhibitors (NNRTIs), and fewer studies guide its treatment. Regimens built on dolutegravir, an integrase inhibitor that is now a standard first-line HIV medicine, appear effective against both types. Prevention medicines protect people who do not have HIV. PrEP (pre-exposure prophylaxis) is taken as a daily pill or an injection every two or six months; taken consistently, it lowers the risk of getting HIV from sex by about 99%. PEP (post-exposure prophylaxis) is a 28-day course of HIV medicines started urgently after a possible exposure.
With ART started early and taken consistently, HIV is a manageable long-term condition. The viral load usually falls over the first months of treatment. Once it is undetectable and stays that way, a person does not pass HIV to sexual partners, a finding often summarized as undetectable equals untransmittable (U=U). Living with HIV means regular care: blood tests to check the viral load and CD4 count, prescription refills or injection appointments, and a check for drug interactions whenever a new medicine is added. Support matters too. Practical and emotional support, healthy habits and regular medical care all contribute to quality of life. Without treatment, HIV usually follows a predictable course. Some people have a flu-like illness in the first weeks, followed by a long stage with few or no symptoms, during which the immune system is gradually damaged. AIDS typically develops after ten years or more, though sometimes sooner. HIV-2 usually progresses more slowly, but most people with it still develop illness over time and benefit from treatment. Having children is possible. HIV medicines taken during pregnancy, birth and breastfeeding greatly reduce the chance of passing HIV to the baby. With an undetectable viral load, the chance of transmission through breastfeeding is under 1%, and feeding with formula or pasteurized donor milk removes it entirely.
Arrange an HIV test if you have never had one, if you or a partner have had sex without a condom or PrEP, have shared injecting equipment, or have been diagnosed with another STI, and as part of pregnancy care. A flu-like illness with fever, rash, sore throat, swollen glands or mouth ulcers in the weeks after a possible exposure can be early HIV. Contact a clinician promptly and mention the recent exposure, since early infection may need a different test. If you may have been exposed to HIV in the past 72 hours, for example through a broken condom with a partner who could have HIV, shared needles or sexual assault, contact a health care provider immediately or go to an emergency room right away to ask about PEP. It must start within 72 hours, and the sooner it starts, the better it works. If you are living with HIV, contact your care team promptly about side effects that make it hard to keep taking your medicines, missed doses or new symptoms, especially if your CD4 count is low, since infections can then be more frequent and more severe.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Lentivirus Infections is like, what's helped you, or ask the community a question.